A detailed history of 17 Capital Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, 17 Capital Partners, LLC holds 5,618 shares of DXCM stock, worth $449,664. This represents 0.25% of its overall portfolio holdings.

Number of Shares
5,618
Previous 7,080 20.65%
Holding current value
$449,664
Previous $802,000 53.12%
% of portfolio
0.25%
Previous 0.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$64.0 - $116.06 $93,568 - $169,679
-1,462 Reduced 20.65%
5,618 $376,000
Q2 2024

Jul 18, 2024

BUY
$110.31 - $140.45 $27,577 - $35,112
250 Added 3.66%
7,080 $802,000
Q1 2024

Apr 11, 2024

BUY
$114.22 - $140.1 $118,217 - $145,003
1,035 Added 17.86%
6,830 $947,000
Q4 2023

Jan 11, 2024

BUY
$75.49 - $124.16 $437,464 - $719,507
5,795 New
5,795 $719,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track 17 Capital Partners, LLC Portfolio

Follow 17 Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 17 Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 17 Capital Partners, LLC with notifications on news.